… ProQR to Present at Upcoming Scientific Meeting and Investor … at 9:30am EST, Daniel de Boer, Chief Executive Officer of ProQR, will present at the LEERINK 7 th Annual Global … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and …
… ProQR Therapeutics Announces Results for the Third Quarter of … today announced results for the third quarter of 2014. "ProQR has made significant accomplishments, both financially … in 2014," said Daniel de Boer, Chief Executive Officer of ProQR. "With the successful completion of our recent initial …
… ProQR to Present at the Chardan Inaugural Gene Therapy … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR Announces Financial Results for the Second Quarter of … said Daniel A. de Boer, chief executive officer of ProQR. “Over the next twelve months, we are looking forward … current cash on hand of €33.0 million (at June 30, 2018), ProQR’s operation is funded into late 2019 Subsequent Events …
… ProQR Therapeutics Announces Results for the First Quarter of … one in a year that is going to be a very exciting one for ProQR," said Daniel de Boer, Chief Executive Officer of ProQR. "We advanced our first pipeline program, QR-110, into …
… ProQR to Present at the Annual Piper Jaffray Healthcare … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR remembers co-founder Henri Termeer after his unexpected … LEIDEN, the Netherlands, May 15, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), remembers co-founder … said Daniel A. de Boer, Chief Executive Officer of ProQR. “Henri was a great mentor, a passionate patient …